Source: International Congress 2018 – Respiratory muscles and lung function: from healthy subjects to patients
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Fernandez (München, Germany), N. Sun (Neuherberg, Germany), M. Wei (Neuherberg, Germany), M. Witting (Neuherberg, Germany), M. Aichler (Neuherberg, Germany), S. Verleden (Leuven, Belgium), P. Schmitt-Kopplin (Neuherberg, Germany), A. Walch (Neuherberg, Germany), O. Eickelberg (München, Germany). Pharmacometabolic effect of pirfenidone treatment in IPF detected by high resolution MALDI-FTICR imaging. 2151

Member's Comments

No comment yet.

Related content which might interest you: Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT) Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 The prevalence and extent of bronchiectasis on high resolution CT scanning in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 600s Year: 2002 Lacunarity analysis enables detection of emphysema progression in COPD smokers using MR imaging of inhaled hyperpolarized helium Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema Year: 2007 Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021 The relationship between the presence of bronchiectasis on high resolution CT scanning and lower airway bacterial colonisation in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 158s Year: 2002 Comparison of in-vivo lung morphometry models from multiple b-value diffusion-weighted MRI in healthy controls, IPF and COPD patients Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017 Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017 Year: 2019 Differential diagnosis between pulmonary fibrosis and lung emphysema by analysis of pixel density distribution of high resolution computed tomography (HRCT) Source: Eur Respir J 2004; 24: Suppl. 48, 68s Year: 2004 Quantitative measurement of airway dimensions on high resolution CT scans and detection of structural lung damage in children who have cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 20s Year: 2002 Late Breaking Abstract - A PET imaging study to confirm target engagement in the lungs of patients with IPF following a single dose of a novel inhaled avß6 integrin inhibitor Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 MMP2 probe based on in vivo imaging technique for tracking ALI/ARDS in mice Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science Year: 2021 High resolution computed tomography quantitation of emphysema is correlated with selected lung function tests values in patients with stable COPD Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010 The magnitude of pirfenidone treatment effect in patients with idiopathic pulmonary fibrosis (IPF): A pooled analysis of outcomes in the CAPACITY (CAP) studies Source: Annual Congress 2010 - New insights in the treatment of idiopathic pulmonary fibrosis Year: 2010 Visualization of intralobular minimal change of emphysema using ultra high resolution CT Source: Annual Congress 2010 - Infection, inflammation and destruction Year: 2010 High resolution computed tomography (HRCT) findings before and after treatment with Interferon gamma - 1b (IFN-γ) or colchicine in idiopathic pulmonary fibrosis (IPF) patients Source: Eur Respir J 2003; 22: Suppl. 45, 592s Year: 2003 Assessment of chest magnetic resonance imaging in non-cystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with clinical and pulmonary function data Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009 In vivo optical imaging for low-risk microscopic diagnosis of IPF Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Ventilation heterogeneity assessed in patients with mild cystic fibrosis and asthma using Hyperpolarised gas MRI histogram analysis Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017 Quantitative multivolume magnetic resonance imaging (1H-MRI) in patients with cystic fibrosis (CF) lung disease:comparison with FEV1 and lung clearance index (LCI) Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers Year: 2017 Comparison of high resolution computerized tomography (HRCT) of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis (CF) patients Source: Eur Respir J 2004; 24: Suppl. 48, 387s Year: 2004